CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-21 | STRAYER DAVID R Chief Science/Medical Officer | Purchase | +2,481 | $4.03 | $10K | 5,420 |
| 2019-05-08 | STRAYER DAVID R Chief Science/Medical Officer | Conversion | +35,000 | 129,304 | ||
| 2019-03-25 | STRAYER DAVID R Chief Science/Medical Officer | Conversion | +50,000 | 94,304 | ||
| 2019-03-04 | STRAYER DAVID R Chief Science/Medical Officer | Option exercise | +10 | 10 | ||
| 2019-03-04 | STRAYER DAVID R Chief Science/Medical Officer | Option exercise | +50,000 | 50,000 | ||
| 2019-03-04 | STRAYER DAVID R Chief Science/Medical Officer | Option exercise · Subr Rights(to buy) | +10 | $1,000.00 | $10K | 0 |
| 2019-01-28 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to buy Common Stock | +184,659 | 184,659 | ||
| 2018-11-27 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award | +2,500 | 44,304 | ||
| 2018-11-14 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to buy Common Stock | +1,000 | 1,000 | ||
| 2018-10-17 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to buy Common Stock | +123,106 | 123,106 | ||
| 2018-04-12 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to buy Common Stock | +75,000 | 75,000 | ||
| 2017-05-02 | STRAYER DAVID R Chief Science/Medical Officer | Purchase | +7,937 | $0.63 | $5K | 41,804 |
| 2017-02-16 | STRAYER DAVID R Chief Science/Medical Officer | Purchase | +9,892 | $0.46 | $5K | 33,867 |
| 2016-07-29 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +20,479 | $0.13 | $3K | 20,479 |
| 2016-07-15 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +22,186 | $0.12 | $3K | 22,186 |
| 2016-06-30 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +22,186 | $0.12 | $3K | 22,186 |
| 2016-06-21 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Options to Buy Common Stock | +150,000 | 150,000 | ||
| 2016-06-15 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +24,203 | $0.11 | $3K | 24,203 |
| 2016-05-31 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +22,186 | $0.12 | $3K | 22,186 |
| 2016-05-15 | STRAYER DAVID R Chief Science/Medical Officer | Grant or award · Incentive Rights | +24,203 | $0.11 | $3K | 24,203 |
Page 1 of 2 · 27 trades